1259 related articles for article (PubMed ID: 25889179)
1. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
2. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
3. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
4. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
5. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.
Mo CF; Wu FC; Tai KY; Chang WC; Chang KW; Kuo HC; Ho HN; Chen HF; Lin SP
Stem Cell Res Ther; 2015 Jan; 6(1):1. PubMed ID: 25559585
[TBL] [Abstract][Full Text] [Related]
6. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
10. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
12. Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.
Anchan R; Gerami-Naini B; Lindsey JS; Ho JW; Kiezun A; Lipskind S; Ng N; LiCausi JA; Kim CS; Brezina P; Tuschl T; Maas R; Kearns WG; Williams Z
PLoS One; 2015; 10(3):e0119275. PubMed ID: 25751620
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
[TBL] [Abstract][Full Text] [Related]
14. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
[TBL] [Abstract][Full Text] [Related]
15. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
16. Generation of iPS Cells from Granulosa Cells.
Mao J; Liu L
Methods Mol Biol; 2016; 1357():451-64. PubMed ID: 25403467
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
18. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
19. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
20. Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.
Li Y; Hong N; Zhang A; Chen W; Wang RH; Xu XL; Deng CX
Cell Death Dis; 2014 Dec; 5(12):e1550. PubMed ID: 25476898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]